FDA Orders Philips Respironics to Notify Patients Regarding the Recall of Certain Breathing Assistance Machines

SILVER SPRING, Md., March 10, 2022 /PRNewswire/ — Today, the U.S. Food and Drug Administration issued a notification order to Philips Respironics requiring the company to notify patients and others of the company’s June 14, 2021, recall of certain Philips Respironics ventilators, continuous…

Source: www.prnewswire.com – Read more